Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=20144403&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Reducing cardiometabolic risk in peritoneal dialysis patients: role of the dialysis solution Holmes CJJ Diabetes Sci Technol 2009[Nov]; 3 (6): 1472-80Peritoneal dialysis (PD) is a well-established form of therapy for stage 5 chronic kidney disease requiring renal replacement therapy. D-Glucose has been used successfully for several decades as the osmotic agent employed in dialysis solutions to achieve adequate fluid removal. The absorption of 100-200 grams of glucose per day has been suggested as potentially increasing cardiometabolic risk, particularly in patients with diabetes. Supporting and undermining evidence for this hypothesis is reviewed, with a focus on the role of glucose absorption in changes in body composition, dyslipidemia, and glycemic control in diabetic PD patients. Clinical strategies to optimize fluid removal while minimizing the metabolic impact of glucose absorption are also discussed.|Adipokines/metabolism[MESH]|Blood Glucose/metabolism[MESH]|Body Mass Index[MESH]|Diabetic Nephropathies/blood/complications/mortality/*therapy[MESH]|Dialysis Solutions/*adverse effects/metabolism[MESH]|Dyslipidemias/blood/etiology[MESH]|Evidence-Based Medicine[MESH]|Glucose/*adverse effects/metabolism[MESH]|Humans[MESH]|Intra-Abdominal Fat/metabolism[MESH]|Kidney Failure, Chronic/blood/complications/mortality/*therapy[MESH]|Metabolic Syndrome/blood/*etiology/mortality/prevention & control[MESH]|Peritoneal Dialysis/*adverse effects/mortality[MESH]|Risk Assessment[MESH]|Risk Factors[MESH]|Weight Gain[MESH] |
